
PMC:7795856 / 234-688
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
19 | 414-417 | Gene | denotes | Tα1 | Gene:134864 |
21 | 421-437 | Species | denotes | Escherichia coli | Tax:562 |
25 | 356-357 | Chemical | denotes | N | MESH:D009584 |
26 | 373-377 | Chemical | denotes | RimJ | |
32 | 93-101 | Disease | denotes | COVID-19 | MESH:C000657245 |
33 | 102-112 | Disease | denotes | infections | MESH:D007239 |
34 | 117-123 | Disease | denotes | cancer | MESH:D009369 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T4 | 117-123 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 125-288 | Sentence | denotes | Manufacturing of this N-terminally acetylated 28-residue peptide is demanding, and its short plasma half-life limits in vivo efficacy and requires frequent dosing. |
T6 | 289-452 | Sentence | denotes | Here, we combined the PASylation technology with enzymatic in situ N-acetylation by RimJ to produce a long-acting version of Tα1 in Escherichia coli at high yield. |